MediLumine Inc.

MediLumine is committed to providing high quality instruments, reagents and accessories for imaging applications in the life sciences. MediLumine’s PRISM™ in vivo imaging system is designed for preclinical monitoring of physiological changes in living systems for therapeutic discovery research. PRISM relies on a photon counting technology for sensitive and real time preclinical imaging. MediLumine’s imaging reagents span a wide array of imaging modalities including micro-CT, optical and magnetic particle imaging allowing scientists to monitor progression of functional liver diseases, quantify tumor burdens, track cancer cells in vivo and visualize angiogenesis.